The following is a guest post by Harold DeMonaco, MS, a member of our editorial team, and Director of the Innovation Support Center at the Massachusetts General Hospital. A graduate of the Massachusetts College of Pharmacy and Allied Health Sciences he holds a bachelors degree in pharmacy and a masters degree in therapeutics. He has [...]
Only when you track health news every day, as we have done for years, can you point to patterns of practice by certain news organizations. We have data to point out which news organizations are more likely to report from news releases. We have data to point out which news organizations are more likely to [...]
That’s an excerpt from a recent commentary in the British Journal of Urology International (BJUI) by authors from urology departments in Canada and the UK asking, “Should we really consider Gleason 6 prostate cancer?” (subscription required for full access). The National Cancer Institute defines the Gleason score as: A system of grading prostate cancer tissue [...]
ESPN has begun another Jimmy V Week for Cancer Research in order to raise awareness and money for cancer research. The week – and The V Foundation for Cancer Research – are named after legendary college basketball coach Jimmy Valvano, who died of metastatic adenocarcinoma just a few weeks after giving this unforgettable speech at [...]
A Kansas City television station produced a good package on local variations in health care practice, and how one medical center is addressing variation by employing shared decision-making. It’s good to see local TV news tackle issues such as this. Worth a look.
This week’s edition of the NEJM includes four perspective pieces on the new US Preventive Services Task Force’s prostate cancer screening recommendations. One, on “what the USPSTF left out,” states: “Although the USPSTF explicitly does not consider costs, policymakers cannot ignore economic aspects of screening. Using data from the European screening trial, researchers have estimated [...]
The PBS NewsHour had a 6-minute segment last night – headlined on their website as “Patients, Doctors Face Tough Questions Amid Changes in Prostate Cancer Screening.” One unusual feature of the segment: it profiled a man who went into septic shock after a prostate biopsy after an elevated PSA test – the kind of cascade [...]
One wonders how many men have their blood tested for PSA levels looking for prostate cancer without being asked if that’s what they really wanted. The Foundation for Informed Medical Decision Making (which supports my web publishing efforts) has now posted on its YouTube page a video clip with a man who has some regrets [...]
In a comment left on my blog, Jamie Bearse, the chief operating officer of Project Zero – The Project to End Prostate Cancer, showed how quickly and deeply discussions about screening tests can devolve into ugly rhetoric. Bearse wrote: “Your comments along with Otis Brawley’s vendetta against the PSA sentence men to die from prostate [...]
It’s State Fair time in Minnesota – a grand time at one of the nation’s best state fairs. Every year, the NBC station in the Twin Cities, KARE-11, offers free health screenings at the fair. TV stations love such events. And this year the added touch was the fact that the big “Drive Against Prostate [...]
It’s difficult to do an overview of melanoma drug research in a relatively brief story. But this story did a solid job.
Better than a competing piece by Reuters but still a little short on some details about this asthma drug study.
An adequate summary of this asthma drug trial’s design doesn’t make up for the overly optimistic tone about the drug’s future. A New York Times story was better.
We will not display your name or e-mail address on the site, nor will we share youre-mail address with any third parties.
For site updates and news from Gary, find us on Twitter:
HealthNewsReview: @HealthNewsRevu
Gary Schwitzer: @garyschwitzer
Copyright © 2013 Health News Review
